Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Colorado Kidney Care · Amgen (United States) · +3 more institutions
Abstract
Mortality rates in ESRD are unacceptably high. Disorders of mineral metabolism (hyperphosphatemia, hypercalcemia, and secondary hyperparathyroidism) are potentially modifiable. For determining associations among disorders of mineral metabolism, mortality, and morbidity in hemodialysis patients, data on 40,538 hemodialysis patients with at least one determination of serum phosphorus and calcium during the last 3 mo of 1997 were analyzed. Unadjusted, case mix-adjusted, and multivariable-adjusted relative risks of death were calculated for categories of serum phosphorus, calcium, calcium x phosphorus product, and intact parathyroid hormone (PTH) using proportional hazards regression. Also determined was whether…
Citation impact
- FWCI
- 49.82
- Percentile
- 100%
- References
- 36
Authors
6- GAGeoffrey A. BlockCorresponding
Colorado Kidney Care
- PKPreston Klassen
Amgen (United States)
- JMJ. Michael Lazarus
Fresenius Medical Care North America (United States), Fresenius Medical Care (United States)
- NJNorma J. Ofsthun
Fresenius Medical Care (United States), Fresenius Medical Care North America (United States)
- EGEdmund G. Lowrie
Fresenius Medical Care (United States), Fresenius Medical Care North America (United States)
Topics & keywords
- Hyperphosphatemia
- Internal medicine
- Medicine
- Hyperparathyroidism
- Hemodialysis
- Secondary hyperparathyroidism
- Parathyroid hormone
- Phosphorus
- Good health and well-being